Predictive value of plasma fibrinogen levels: In patients admitted for acute coronary syndrome

Texas Heart Institute Journal

Volumn 37, Issue 2, 2010, Pages 178-183

  Shi, Yu ^a   Wu, Yihua ^a   Bian, Chang ^a   Zhang, Wanjun ^a   Yang, Jun ^a   Xu, Geng ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute phase proteins; Biological markers blood; Cardiovascular diseases blood etiology; Coronary disease complications physiopathology; Fibrinogen analysis classification; Logistic models; Multivariate analysis; Predictive value of tests; Prognosis; Risk factors; Survival analysis

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ADULT; AGE; ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK FACTOR; SEX; AGED; ANGIOCARDIOGRAPHY; BLOOD; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CORONARY ARTERY OBSTRUCTION; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; RECURRENT DISEASE; RISK; RISK ASSESSMENT; STATISTICAL MODEL; TIME;

ACUTE CORONARY SYNDROME; ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FEMALE; FIBRINOGEN; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 77954946332     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lesperance F, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 2008;118(17): 1768-75.
2. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994;331(7):417-24.
3. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999;99(7):855-60.
4. Clauss A. Rapid physiological coagulation method in determination of fibrinogen [in German]. Acta Haematol 1957;17(4): 237-46.
5. Fibrinogen as a risk factor in cardiovascular disease. N Engl J Med 1985;312(2):120-1.
6. Stec JJ, Silbershatz H, Tofler GH, Matheney TH, Sutherland P, Lipinska I, et al. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation 2000;102(14):1634-8.
7. Fibrinogen Studies Collaboration, Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and non-vascular mortality: an individual participant meta-analysis. JAMA 2005;294(14):1799-809.
8. Jose J, Selvakumar D, Selvakumar R, Kanagasapabathy AS, Jeyaseelan L. Plasma fibrinogen--an independent risk factor for ischaemic heart disease. Indian Heart J 1998;50(1):45-8.
9. Mehta JL, Saldeen TG, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 1998;31(6): 1217-25.
10. Becker AE, de Boer OJ, van Der Wal AC. The role of inflammation and infection in coronary artery disease. Annu Rev Med 2001;52:289-97.
11. Neri Serneri GG, Prisco D, Martini F, Gori AM, Brunelli T, Poggesi L, et al. Acute T-cell activation is detectable in unstable angina. Circulation 1997;95(7):1806-12.
12. Hosono M, de Boer OJ, van der Wal AC, van der Loos CM, Teeling P, Piek JJ, et al. Increased expression of T cell activation markers (CD25, CD26, CD40L and CD69) in ather-ectomy specimens of patients with unstable angina and acute myocardial infarction. Atherosclerosis 2003;168(1):73-80.
13. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990;12(5):1179-86.
14. Rebuzzi AG, Quaranta G, Liuzzo G, Caligiuri G, Lanza GA, Gallimore JR, et al. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris. Am J Cardiol 1998;82(6):715-9.
15. Blake GJ, Ridker PM. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 2003;41(4 Suppl S):37S-42S.
16. Humphries SE. Genetic regulation of fibrinogen. Eur Heart J 1995;16 Suppl A:16-20.
17. Dejana E, Languino LR, Polentarutti N, Balconi G, Ryck-ewaert JJ, Larrieu MJ, et al. Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest 1985;75(1):11-8.
18. Retzinger GS, DeAnglis AP, Patuto SJ. Adsorption of fibrino-gen to droplets of liquid hydrophobic phases. Functionality of the bound protein and biological implications. Arterioscler Thromb Vasc Biol 1998;18(12):1948-57.
19. Bodary SC, Napier MA, McLean JW. Expression of recombi-nant platelet glycoprotein IIbIIIa results in a functional fibrin-ogen-binding complex. J Biol Chem 1989;264(32):18859-62.
20. Lowe GD, Fowkes FG, Dawes J, Donnan PT, Lennie SE, Housley E. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 1993;87(6):1915-20.
21. Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Circulation 1997;96(12):4204-10.
22. Becker RC, Cannon CP, Bovill EG, Tracy RP, Thompson B, Knatterud GL, et al. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial). Am J Cardiol 1996;78(2):142-7.
23. Pellizzon GG, Dixon SR, Stone GW, Cox DA, Mattos L, Boura JA, et al. Relation of admission white blood cell count to long-term outcomes after primary coronary angioplasty for acute myocardial infarction (The Stent PAMI Trial). Am J Cardiol 2003;91(6):729-31.